🔎 Trials Near Me

Akèy › Glomeruloskleroz fokal segmantè › Kalifòni › San Francisco

Etid klinik pou Glomeruloskleroz fokal segmantè nan San Francisco, CA

3 etid pou Glomeruloskleroz fokal segmantè ap chèche patisipan nan sit nan ak bò kote San Francisco (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)

Ap rekriteFaz 3
  • Kaiser Permanente - French Campus, San Francisco
Laj 12 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07220083

A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease

Ap rekriteFaz 2
  • University of California San Francisco - Parnassus Heights- Site Number : 8400012, San Francisco
Laj 16 a 75 · Tout sèks · Mizajou Sep 23, 2026 · NCT06500702

Nephrotic Syndrome Study Network

Ap rekriteEtid obsèvasyon
  • University of California San Francisco Benioff Children's Hospitals, San Francisco
Jiska laj 80 · Tout sèks · Mizajou Jun 10, 2026 · NCT01209000

Etid Glomeruloskleroz fokal segmantè nan lòt vil

Lòt etid nan San Francisco

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.